top of page

Sciences behind

Highly effective in inhibiting polymicrobial growth

Against other pathogenic bacteria and fungus

Besides, Lassica K014™ is found to be equally effective in inhibiting other fungal-bacterial colonisation, including Escherichia coli, Propionibacterium acnes and Candida albicans. This broad-spectrum activity reduces the risks of enhanced pathogenicity of co-infections attributable to polymicrobial interaction of Staphylococcus aureus and Candida albicans in human guts.

Against MRSA

Our studies found that Lassica K014™ is capable of killing 96.1% of Methicillin-resistant Staphylococcus aureus (MRSA) colonies, which is comparable to commercially available antibiotics such as ampicillin, chloramphenicol and vancomycin

Commensal bacteria and fungi cell counts in the faeces of healthy laboratory rats before and after oral administration of Lassica K014 within 24 hours

Screenshot 2023-09-07 at 10.55.13 PM.png

Under the scanning electron microscopy, it is observed that MRSA cell structures rupture when treated with Lassica K014™ (see figure below). 

Screenshot 2023-09-05 at 11.24.35 PM.png
Treated with
Lassica K014

Comparing Anti-MRSA Activities of Lassica K014™ with Antibiotics

Promoting balanced microbiota in gut

Our in-house animal study shows that single dose of Lassica K014 increases lactic acid bacteria (LAB) cell counts within 24 hours (see diagram below) and reduces the opportunistic pathogens. Studies found that polymicrobial interaction of these opportunistic pathogens in human guts can contribute to enhanced pathogenicity of co-infections. This suggests that the use of Lassica K014 can have positive impact on gut health.

Inhibitory efficacy % against other pathogens

Escherichia coli

Candida albicans

Propionibacterium acnes

Streptococcus mutans

Featured in

The Petri Dish logo.png

Gold-award-winning Ingredient

bottom of page